Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2021 Jun 23;24(2):601. doi: 10.3892/mmr.2021.12239

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Yu et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 5. — Levels of TATc, TFPI, PAI-1, FV activity and FDP in lung homogenates of the three treatment groups. Levels of (A) TATc, (B) TFPI, (C) PAI-1, and (E) FDP as well as (D) FV activity in lung homogenates. Data are shown as the mean ± standard deviation (n=5–9 mice/group). **P<0.01, ****P<0.0001 and NS = no significance, by one-way ANOVA followed by Tukey's multiple-comparison test. TATc, thrombin-antithrombin complex; TFPI, tissue factor pathway inhibitor; PAI-1, plasminogen activator inhibitor-1; FV, factor V; FDP, fibrin degradation product.